{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:15Z","timestamp":1786980135248,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Novartis Farma, Origgio, Varese, Italy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00415-017-8642-5","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T17:25:23Z","timestamp":1508779523000},"page":"2436-2449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing\u2013remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)"],"prefix":"10.1007","volume":"264","author":[{"name":"For the Golden Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Assunta","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Caterina","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pozzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sacc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian Then","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bartezaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Turrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"issue":"3","key":"8642_CR1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O\u2019Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stuve O, Waubant E, Polman CH (2014) Defining the clinical course of multiple sclerosis The 2013 revisions. Neurology 83(3):278\u2013286","journal-title":"Neurology"},{"issue":"1\u20132","key":"8642_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jns.2005.08.019","volume":"245","author":"MP Amato","year":"2006","unstructured":"Amato MP, Zipoli V, Portaccio E (2006) Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci 245(1\u20132):41\u201346. doi:\n                        10.1016\/j.jns.2005.08.019","journal-title":"J Neurol Sci"},{"issue":"12","key":"8642_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7(12):1139\u20131151. doi:\n                        10.1016\/S1474-4422(08)70259-X","journal-title":"Lancet Neurol"},{"issue":"1","key":"8642_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/1352458508096684","volume":"15","author":"F Patti","year":"2009","unstructured":"Patti F (2009) Cognitive impairment in multiple sclerosis. Mult Scler 15(1):2\u20138. doi:\n                        10.1177\/1352458508096684","journal-title":"Mult Scler"},{"issue":"6","key":"8642_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s00415-012-6678-0","volume":"260","author":"MP Amato","year":"2013","unstructured":"Amato MP, Langdon D, Montalban X, Benedict RH, DeLuca J, Krupp LB, Thompson AJ, Comi G (2013) Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol 260(6):1452\u20131468. doi:\n                        10.1007\/s00415-012-6678-0","journal-title":"J Neurol"},{"key":"8642_CR6","doi-asserted-by":"publisher","unstructured":"Rosti-Otajarvi EM, Hamalainen PI (2014) Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev (2):CD009131. doi:\n                        10.1002\/14651858.CD009131.pub3","DOI":"10.1002\/14651858.CD009131.pub3"},{"issue":"5","key":"8642_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1056\/NEJMoa0907839","volume":"362","author":"JA Cohen","year":"2010","unstructured":"Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L, Group TS (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362(5):402\u2013415. doi:\n                        10.1056\/NEJMoa0907839","journal-title":"N Engl J Med"},{"issue":"11","key":"8642_CR8","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1517\/13543784.2012.716036","volume":"21","author":"F Patti","year":"2012","unstructured":"Patti F (2012) Treatment of cognitive impairment in patients with multiple sclerosis. Expert Opin Investig Drugs 21(11):1679\u20131699. doi:\n                        10.1517\/13543784.2012.716036","journal-title":"Expert Opin Investig Drugs"},{"issue":"9","key":"8642_CR9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O\u2019Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW, Investigators A (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354(9):899\u2013910. doi:\n                        10.1056\/NEJMoa044397","journal-title":"N Engl J Med"},{"key":"8642_CR10","volume-title":"A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis","author":"SM Rao","year":"1990","unstructured":"Rao SM, The Cognitive Function Study Group of the National Multiple Sclerosis Society (1990) A manual for the brief repeatable battery of neuropsychological tests in multiple sclerosis. Medical College of Wisconsin, Milwaukee"},{"issue":"6","key":"8642_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1177\/1352458511431076","volume":"18","author":"DW Langdon","year":"2012","unstructured":"Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hamalainen P, Hartung HP, Krupp L, Penner IK, Reder AT, Benedict RH (2012) Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler 18(6):891\u2013898. doi:\n                        10.1177\/1352458511431076","journal-title":"Mult Scler"},{"issue":"2","key":"8642_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/13803390600672163","volume":"29","author":"BA Parmenter","year":"2007","unstructured":"Parmenter BA, Zivadinov R, Kerenyi L, Gavett R, Weinstock-Guttman B, Dwyer MG, Garg N, Munschauer F, Benedict RHB (2007) Validity of the Wisconsin card sorting and Delis\u2013Kaplan executive function system (DKEFS) sorting tests in multiple sclerosis. J Clin Exp Neuropsychol 29(2):215\u2013223. doi:\n                        10.1080\/13803390600672163","journal-title":"J Clin Exp Neuropsychol"},{"key":"8642_CR13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","volume":"18","author":"JR Stroop","year":"1935","unstructured":"Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643\u2013662","journal-title":"J Exp Psychol"},{"key":"8642_CR14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) New depression scale designed to be sensitive to change. Br J Psychiatr 134:382\u2013389","journal-title":"Br J Psychiatr"},{"issue":"5","key":"8642_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1212\/WNL.0b013e31824528c9","volume":"78","author":"MP Amato","year":"2012","unstructured":"Amato MP, Hakiki B, Goretti B, Rossi F, Stromillo ML, Giorgio A, Roscio M, Ghezzi A, Guidi L, Bartolozzi ML, Portaccio E, De Stefano N, Italian RISMSSG (2012) Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. Neurology 78(5):309\u2013314. doi:\n                        10.1212\/WNL.0b013e31824528c9","journal-title":"Neurology"},{"issue":"9","key":"8642_CR16","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","volume":"66","author":"M Calabrese","year":"2009","unstructured":"Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66(9):1144\u20131150. doi:\n                        10.1001\/archneurol.2009.174","journal-title":"Arch Neurol"},{"issue":"3","key":"8642_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","volume":"14","author":"MA Rocca","year":"2015","unstructured":"Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, Rovira A, Sumowski JF, Valsasina P, Filippi M, Grp MS (2015) Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 14(3):302\u2013317. doi:\n                        10.1016\/S1474-4422(14)70250-9","journal-title":"Lancet Neurol"},{"issue":"5","key":"8642_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O\u2019Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P, Grp FS (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362(5):387\u2013401. doi:\n                        10.1056\/NEJMoa0909494","journal-title":"N Engl J Med"},{"issue":"2","key":"8642_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40263-015-0297-0","volume":"30","author":"SF Hunter","year":"2016","unstructured":"Hunter SF, Bowen JD, Reder AT (2016) The direct effects of fingolimod in the central nervous system: implications for relapsing multiple sclerosis. CNS Drugs 30(2):135\u2013147. doi:\n                        10.1007\/s40263-015-0297-0","journal-title":"CNS Drugs"},{"issue":"9","key":"8642_CR20","first-page":"A611","volume":"76","author":"J Pelletier","year":"2011","unstructured":"Pelletier J, Karlsson G, Li BB, De Vera A, Francis G, Cohen J, Kappos L (2011) Effect of fingolimod on multiple sclerosis functional composite (MSFC) defined disability progression in patients with relapsing remitting MS (RRMS): results from two phase III studies. Neurology 76(9):A611","journal-title":"Neurology"},{"key":"8642_CR21","first-page":"210","volume":"20","author":"Y Barak","year":"2014","unstructured":"Barak Y, Magalashvili D, Paz T, Achiron A (2014) Fingolimod (Gilenya) confers cognitive stability in active relapsing\u2013remitting multiple sclerosis patients. Mult Scler J 20:210","journal-title":"Mult Scler J"},{"key":"8642_CR22","doi-asserted-by":"publisher","first-page":"389360","DOI":"10.1155\/2015\/389360","volume":"2015","author":"J Fonseca","year":"2015","unstructured":"Fonseca J (2015) Fingolimod real world experience: efficacy and safety in clinical practice. Neurosci J 2015:389360. doi:\n                        10.1155\/2015\/389360","journal-title":"Neurosci J"},{"issue":"S16","key":"8642_CR23","first-page":"P12.150","volume":"86","author":"D Langdon","year":"2016","unstructured":"Langdon D, Penner I-K, Calabrese P, Cutter G, H\u00e4ring D, Dahlke F, Tomic D, Kappos L (2016) Fingolimod effects on PASAT score and baseline determinants of PASAT in a large cohort of RRMS patients. Neurology 86(S16):P12.150","journal-title":"Neurology"},{"issue":"S16","key":"8642_CR24","first-page":"P13.071","volume":"86","author":"S Ozakbas","year":"2016","unstructured":"Ozakbas S, Cinar BP, Kosehasanogullari G, Yigit P (2016) Effects of fingolimod on cognitive status in patients with multiple sclerosis: prospective, controlled trial. Neurology 86(S16):P13.071","journal-title":"Neurology"},{"issue":"6","key":"8642_CR25","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O\u2019Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria\u201d. Ann Neurol 58(6):840\u2013846. doi:\n                        10.1002\/ana.20703","journal-title":"Ann Neurol"},{"key":"8642_CR26","unstructured":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (1996) ICH harmonised tripartite guideline. Guideline for good clinical practice. \n                        http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6_R1\/Step4\/E6_R1__Guideline.pdf\n                        \n                    . Accessed 2 Aug 2017"},{"key":"8642_CR27","unstructured":"World Medical Association Declaration of Helsinki (2017) Ethical principles for medical research involving human subjects. \n                        http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/index.html\n                        \n                    . Accessed 2 Aug 2017"},{"issue":"5","key":"8642_CR28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1212\/WNL.41.5.685","volume":"41","author":"SM Rao","year":"1991","unstructured":"Rao SM, Leo GJ, Bernardin L, Unverzagt F (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41(5):685\u2013691","journal-title":"Neurology"},{"issue":"1","key":"8642_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10072-013-1558-7","volume":"35","author":"B Goretti","year":"2014","unstructured":"Goretti B, Patti F, Cilia S, Mattioli F, Stampatori C, Scarpazza C, Amato MP, Portaccio E (2014) The Rao\u2019s brief repeatable battery version B: normative values with age, education and gender corrections in an Italian population. Neurol Sci 35(1):79\u201382. doi:\n                        10.1007\/s10072-013-1558-7","journal-title":"Neurol Sci"},{"issue":"2","key":"8642_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1017\/S1355617704102191","volume":"10","author":"DC Delis","year":"2004","unstructured":"Delis DC, Kramer JH, Kaplan E, Holdnack J (2004) Reliability and validity of the Delis\u2013Kaplan executive function system: an update. J Int Neuropsychol Soc 10(2):301\u2013303. doi:\n                        10.1017\/S1355617704102191","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"8642_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000047940","volume":"47","author":"Y Barak","year":"2002","unstructured":"Barak Y, Achiron A (2002) Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol 47(1):11\u201314. doi:\n                        10.1159\/000047940","journal-title":"Eur Neurol"},{"issue":"6","key":"8642_CR32","first-page":"457","volume":"9","author":"S Flechter","year":"2007","unstructured":"Flechter S, Vardi J, Finkelstein Y, Pollak L (2007) Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1\u00a0year study. Isr Med Assoc J 9(6):457\u2013459","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"8642_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/1352458509350309","volume":"16","author":"F Patti","year":"2010","unstructured":"Patti F, Amato MP, Bastianello S, Caniatti L, Di Monte E, Ferrazza P, Goretti B, Gallo P, Morra VB, Lo Fermo S, Picconi O, Tola MR, Trojano M, Grp CS (2010) Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler 16(1):68\u201377. doi:\n                        10.1177\/1352458509350309","journal-title":"Mult Scler"},{"key":"8642_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/brain\/120.2.289","volume":"120","author":"P Kujala","year":"1997","unstructured":"Kujala P, Portin R, Ruutiainen J (1997) The progress of cognitive decline in multiple sclerosis\u2014a controlled 3-year follow-up. Brain 120:289\u2013297. doi:\n                        10.1093\/brain\/120.2.289","journal-title":"Brain"},{"issue":"1","key":"8642_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/13803395.2010.481620","volume":"33","author":"C Forn","year":"2011","unstructured":"Forn C, Belenguer A, Belloch V, Sanjuan A, Parcet MA, Avila C (2011) Anatomical and functional differences between the paced auditory serial addition test and the symbol digit modalities test. J Clin Exp Neuropsychol 33(1):42\u201350. doi:\n                        10.1080\/13803395.2010.481620","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"8642_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.msard.2015.03.004","volume":"4","author":"R Karabudak","year":"2015","unstructured":"Karabudak R, Dahdaleh M, Aljumah M, Alroughani R, Alsharoqi IA, AlTahan AM, Bohlega SA, Daif A, Deleu D, Amous A, Inshasi JS, Rieckmann P, Sahraian MA, Yamout BI (2015) Functional clinical outcomes in multiple sclerosis: current status and future prospects. Mult Scler Relat Disord 4(3):192\u2013201. doi:\n                        10.1016\/j.msard.2015.03.004","journal-title":"Mult Scler Relat Disord"},{"issue":"20","key":"8642_CR37","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1212\/WNL.0b013e3181c1de4f","volume":"73","author":"J Bellmann-Strobl","year":"2009","unstructured":"Bellmann-Strobl J, Wuerfel J, Aktas O, Dorr J, Wernecke KD, Zipp F, Paul F (2009) Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis. Neurology 73(20):1624\u20131627. doi:\n                        10.1212\/WNL.0b013e3181c1de4f","journal-title":"Neurology"},{"key":"8642_CR38","first-page":"687","volume":"22","author":"P Iaffaldano","year":"2016","unstructured":"Iaffaldano P, Viterbo RG, Lucisano G, Trojano M (2016) Comparative effectiveness of natalizumab and fingolimod treatment on cognitive functions in relapsing multiple sclerosis. Mult Scler J 22:687","journal-title":"Mult Scler J"},{"issue":"2","key":"8642_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40263-014-0140-z","volume":"28","author":"N Stefano De","year":"2014","unstructured":"De Stefano N, Airas L, Grigoriadis N, Mattle HP, O\u2019Riordan J, Oreja-Guevara C, Sellebjerg F, Stankoff B, Walczak A, Wiendl H, Kieseier BC (2014) Clinical relevance of brain volume measures in multiple sclerosis. CNS Drugs 28(2):147\u2013156. doi:\n                        10.1007\/s40263-014-0140-z","journal-title":"CNS Drugs"},{"issue":"9","key":"8642_CR40","first-page":"A194","volume":"74","author":"L Kappos","year":"2010","unstructured":"Kappos L, O\u2019Connor P, Polman C, Hohlfeld R, Radue EW, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Grp FS (2010) Oral fingolimod (FTY720) vs placebo in relapsing\u2013remitting multiple sclerosis: 24-month clinical efficacy results from a randomized, double-blind, placebo-controlled, multicenter phase III study (FREEDOMS). Neurology 74(9):A194","journal-title":"Neurology"},{"issue":"23","key":"8642_CR41","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1212\/WNL.0b013e318200d768","volume":"75","author":"M Filippi","year":"2010","unstructured":"Filippi M, Rocca MA, Benedict RH, DeLuca J, Geurts JJ, Rombouts SA, Ron M, Comi G (2010) The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 75(23):2121\u20132128. doi:\n                        10.1212\/WNL.0b013e318200d768","journal-title":"Neurology"},{"issue":"8","key":"8642_CR42","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1212\/Wnl.0000000000001281","volume":"84","author":"EW Radue","year":"2015","unstructured":"Radue EW, Barkhof F, Kappos L, Sprenger T, Haring DA, de Vera A, von Rosenstiel P, Bright JR, Francis G, Cohen JA (2015) Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis. Neurology 84(8):784\u2013793. doi:\n                        10.1212\/Wnl.0000000000001281","journal-title":"Neurology"},{"key":"8642_CR43","first-page":"125","volume":"98","author":"AL Traboulsee","year":"2006","unstructured":"Traboulsee AL, Li DK (2006) The role of MRI in the diagnosis of multiple sclerosis. Adv Neurol 98:125\u2013146","journal-title":"Adv Neurol"},{"key":"8642_CR44","first-page":"14","volume":"2012","author":"K Rahn","year":"2012","unstructured":"Rahn K, Slusher B, Kaplin A (2012) Cognitive impairment in multiple sclerosis: a forgotten disability remembered. Cerebrum 2012:14","journal-title":"Cerebrum"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-017-8642-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-017-8642-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T05:30:59Z","timestamp":1510723859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-017-8642-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["8642"],"URL":"https:\/\/doi.org\/10.1007\/s00415-017-8642-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]}}}